An Israel-based start-up has invented a novel pregnancy test kit — SaliStick, that uses the saliva to determine pregnancy. The kit has been launched in Israel and will be available in the global markets from 2023. The diagnostics breakthrough SaliStick test provides precise findings in no more than 10 minutes, without the requirement for a blood or urine sample.
“Saliva is the key to rapid diagnostics for a variety of medical reasons. It is the only non-invasive, easy, and hygienic means to detect hormones, viruses, and even diseases,” said Prof Aaron Palmon, Co-founder of Salignostics.
“With SaliStick, we leverage the powerful diagnostics abilities we have been able to create from analyzing saliva. This product completely removes the need for blood and urine samples when testing for pregnancy,” Prof Aaron added.
The start-up firm has built a new manufacturing plant with a one million unit monthly production capacity in northern Israel’s Lavon Industrial Zone .
In 2016, a group of academics from the Hebrew University of Jerusalem had established Salignostics.
After conducting years of scientific study on saliva, the founders of the company created user-friendly devices that precisely diagnose diseases including malaria, Covid-19, heart risk, and other conditions.
In order to support sales, marketing, and R&D, the firm has so far secured $16 million in total capital investment and is seeking more funds from investors.(WION)